Latest Capital Raises News

FortifAI Limited has raised $5 million through a strategic placement led by a major Australian institutional fund manager, reinforcing its balance sheet and accelerating its AI development and commercialisation plans.

Kuniko Limited has raised A$3.75 million in a strongly supported placement to fast-track drilling and resource expansion at its Commonwealth Gold–Silver Project in NSW’s Lachlan Fold Belt. Phase I drilling is underway, with results expected in April 2026.

Contact Energy has issued over 51 million new shares at NZD 8.75 each, representing a 5.17% increase in its ordinary shares, aiming to strengthen its shareholder base through a carefully structured placement.

Cambium Bio has secured FDA clearance to begin Phase 3 dosing for its lead ophthalmology product, Elate Ocular®, alongside key global partnerships and a $2.4 million capital injection from a major shareholder.

Recharge Metals Limited has inked a binding deal to acquire the Sunset Well Gold Project in Western Australia's Leonora district, featuring a 94,500-ounce inferred gold resource. The company has also secured $5.75 million in capital to kickstart drilling and exploration activities.

Identitii Limited has reopened its pro rata rights issue following a Takeovers Panel ruling, granting shareholders withdrawal rights and terminating the underwriting agreement.

Cobram Estate Olives reported a widened half-year loss driven by higher oil costs and operating expenses, while progressing its US growth strategy with a major California acquisition.

Energy Resources of Australia reported a significantly reduced net loss of $50 million for 2025, driven by rehabilitation provision adjustments and higher interest income. Meanwhile, rehabilitation delays and Rio Tinto’s compulsory acquisition efforts highlight ongoing operational and ownership challenges.

AdAlta Limited reported a $2.44 million loss for H1 FY26 while progressing a key CAR-T therapy collaboration and raising $2.8 million in capital. The company’s ‘East to West’ immunotherapy strategy gains momentum with regulatory tailwinds and cost efficiencies.

LGI Limited reported robust half-year results for December 2025, showcasing strong revenue and profit growth alongside operational expansion and strategic debt repayment.

Megaport Limited reported a robust 49% increase in Annual Recurring Revenue to A$338 million for H1 FY26, driven by organic growth and key acquisitions. The company raised its FY26 revenue guidance and delivered strong EBITDA growth while expanding its global footprint.

Intelligent Monitoring Group Limited has significantly reduced its half-year loss while increasing revenue and adjusted EBITDA, driven by organic growth and key acquisitions in Australia and New Zealand.